Condition: Head and Neck Squamous Cell Carcinoma · Sponsor: Rajiv Gandhi Cancer Institute & Research Center, India
DE-HyART is a phase II clinical trial aimed at understanding the effects of escalating radiation doses to hypoxic sub-volumes inherent to squamous cell head and neck cancer. The study is aimed at assessing locoregional control, feasibility, and acceptable toxicity with such a strategy.
This description comes directly from the study's public registry record.
Sarthak Tandon, DNB · +911147022009 · tandon.sarthak@rgcirc.org
Always discuss trial participation with your own doctor first.
| Rajiv Gandhi Cancer Institute and Research Centre | Delhi, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06087614